Warhound Secures $200M to Engineer Elite Military Canines with Anduril Tech

The U.S. military has long relied on imported working dogs, a dependency that has become increasingly difficult to sustain as the domestic supply dwindles. To address this gap, a new venture called Warhound emerged from stealth on Thursday, revealing a $200 million funding round led by prominent investors including Sequoia, 8VC, Corner Ventures, and In-Q-Tel, the venture arm of U.S. intelligence agencies.

The company, which is now valued at $1.2 billion, is a joint effort between Ben Lamm of Colossal Biosciences and Palmer Luckey of Anduril. Their strategy involves combining genetic engineering with advanced hardware to create canines specifically optimized for dangerous tasks such as bomb detection and specialized searches. Warhound’s launch announcement highlighted that over 80% of the U.S. military’s working dogs are sourced from Europe, with fewer than half of those imports being fit for service upon arrival.

The core of Warhound’s approach is to use Colossal’s biotechnology to breed dogs with traits suited for demanding missions. Lamm explained that he and Luckey first met at a conference about a year ago, where the issue of military dog welfare and performance was discussed. Subsequent research revealed that many working dogs fail to complete training due to inherited issues like poor eyesight, hip dysplasia, muscle atrophy, or a high predisposition to cancer. By studying top-performing breeds like the Belgian Malinois and German Shepherd, the team is developing cell lines to edit genes that enhance health, longevity, speed, and olfactory sensitivity.

While Colossal handles the biological engineering, Anduril is responsible for the technological overlay. The defense tech firm will supply software and hardware, including protective vests and goggles, designed to improve situational awareness for both the dogs and their handlers. Lamm described the vision as adding sensors to equipment that transmit data back to handlers, effectively making the dogs safer and more effective in the field. He emphasized that these enhancements are applied “on top of the dog, not in the dog,” working in tandem with the genetic improvements to better protect human personnel.

The partnership structure involves Colossal licensing its technology to Warhound in exchange for equity, while Luckey serves as a partner without owning a stake in the company. Colossal, previously known for its de-extinction projects aimed at reviving species like the mammoth, is leveraging its experience in gene cloning and AI-driven biological research for this new venture. Viagen, another company under the Colossal umbrella, will handle the actual cloning process, utilizing a technology that boasts a high success rate currently used in endangered species conservation.

The first batch of these engineered dogs is expected to be cloned and incubated shortly, with births anticipated in early 2027 and service entry ideally occurring within two years. While the company has not yet finalized pricing, it plans to sell to the Department of Defense, various military branches, police forces, and other first responder units. Lamm noted that the company has already briefed numerous government groups on the project, though specific details on approval processes remain under discussion.

To address potential concerns regarding the treatment of genetically modified animals, Warhound is working under the guidance of the American Humane Society. The organization is helping to certify the training program for the new canines. Additionally, the company hopes that when these dogs retire from service, they will be placed through the Society’s Military Working Dog Reunification Program, which provides homes for retired military animals.

The American Humane Society issued a statement welcoming the collaboration, noting, “We applaud Warhound and Colossal for inviting the country’s first national humane organization, which is grounded in science and ethics, to have a seat at the table.” The group expressed its intent to work closely with the startup to ensure the animals are treated humanely throughout their service and retirement.